title: Optimizing immunosuppression: who can do more with less?
authors: Glickman Urological and Kidney Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.
authors: Stuart M
authors: SM
authors: Flechner
mesh_terms: D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000592:standards* / Q000639:trends; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016030:Kidney Transplantation / Q000009:adverse effects / Q000379:methods* / Q000401:mortality*; D008297:Male; D020714:Maximum Tolerated Dose; D008875:Middle Aged; D063868:Patient Outcome Assessment; D011379:Prognosis; D012016:Reference Values; D018570:Risk Assessment; D016019:Survival Analysis; D014181:Transplantation Immunology / Q000502:physiology
chemical_list: D007166:Immunosuppressive Agents